8.00
price up icon3.36%   0.26
after-market Dopo l'orario di chiusura: 8.01 0.010 +0.12%
loading

Enanta Pharmaceuticals Inc Borsa (ENTA) Ultime notizie

pulisher
10:46 AM

Visualizing Enanta Pharmaceuticals Inc. stock with heatmapsTrade Risk Summary & Expert Curated Trade Setup Alerts - Newser

10:46 AM
pulisher
06:37 AM

Pattern recognition hints at Enanta Pharmaceuticals Inc. upsideQuarterly Market Summary & Weekly Stock Breakout Alerts - Newser

06:37 AM
pulisher
05:26 AM

Sentiment analysis tools applied to Enanta Pharmaceuticals Inc.CPI Data & Weekly Breakout Watchlists - Newser

05:26 AM
pulisher
08:03 AM

Enanta Pharmaceuticals Inc. Stock Chart Analysis: Bullish or Bearish Pattern Forming2025 Geopolitical Influence & Daily Risk Controlled Trade Plans - Newser

08:03 AM
pulisher
07:44 AM

Does Enanta Pharmaceuticals Inc. qualify in momentum factor screeningPortfolio Growth Summary & Growth-Oriented Investment Plans - Newser

07:44 AM
pulisher
03:58 AM

Will Enanta Pharmaceuticals Inc. continue its uptrendMarket Activity Report & Daily Profit Focused Stock Screening - Newser

03:58 AM
pulisher
03:10 AM

Detecting price anomalies in Enanta Pharmaceuticals Inc. with AIProfit Target & Fast Gain Swing Trade Alerts - Newser

03:10 AM
pulisher
02:15 AM

Can volume confirm reversal in Enanta Pharmaceuticals Inc.2025 Price Momentum & Community Driven Trade Alerts - Newser

02:15 AM
pulisher
12:01 PM

Order flow analysis tools used on Enanta Pharmaceuticals Inc.Insider Selling & Daily Market Momentum Tracking - Newser

12:01 PM
pulisher
Aug 14, 2025

Real time social sentiment graph for Enanta Pharmaceuticals Inc.Trade Ideas & Verified Technical Signals - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year - simplywall.st

Aug 14, 2025
pulisher
Aug 14, 2025

Enanta Pharmaceuticals Inc. Stock Lags Behind Sector Benchmarks2025 Market Outlook & Long-Term Investment Growth Plans - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Published on: 2025-08-15 02:39:05 - kangso.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

How high can Enanta Pharmaceuticals Inc. stock go2025 Sector Review & Daily Oversold Bounce Ideas - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Enanta Pharmaceuticals’ SWOT analysis: stock outlook amid pipeline shifts - Investing.com

Aug 14, 2025
pulisher
Aug 13, 2025

What MACD and RSI say about Enanta Pharmaceuticals Inc.Gold Moves & Fast Entry Momentum Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Has Enanta Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility Review2025 Fundamental Recap & Daily Volume Surge Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

JMP Securities Issues Positive Forecast for Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price - Defense World

Aug 13, 2025
pulisher
Aug 12, 2025

Enanta Pharmaceuticals shares rise 3.91% intraday after Q3 earnings beat expectations and RSVHR trial enrollment completion. - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Enanta: JMP Securities Raises PT to $25 from $24, Maintains Market Outperform Rating - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Citizens JMP raises Enanta Pharmaceuticals stock price target to $25 from $24 - Investing.com Canada

Aug 12, 2025
pulisher
Aug 12, 2025

Enanta Pharmaceuticals Sees Narrower Losses And Brighter Analyst Views - Finimize

Aug 12, 2025
pulisher
Aug 12, 2025

Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot - Stamford Advocate

Aug 12, 2025
pulisher
Aug 12, 2025

Top chart patterns to watch in Enanta Pharmaceuticals Inc.Free Capital Growth With Controlled Risk Picks - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2025 - BioSpace

Aug 12, 2025
pulisher
Aug 12, 2025

Enanta Pharmaceuticals Reports Steady Progress in Q3 2025 - TipRanks

Aug 12, 2025
pulisher
Aug 11, 2025

What makes Enanta Pharmaceuticals Inc. stock price move sharplyFree Entry Plan for Oversold Reversal Stocks - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates - sharewise.com

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Pharmaceuticals Q3 Earnings: $18.3M Loss, $0.85 Per Share - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Pharmaceuticals shares rise 1.85% after-hours following positive RSVHR trial progress and FDA label expansion approval. - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Q3 FY22 Revenue Down 17% YoY, Operations Supported by $204.1mln. - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Leading vs lagging indicators on Enanta Pharmaceuticals Inc. performanceFree Daily Profit Focused Stock Screener - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Will Enanta Pharmaceuticals Inc. price bounce be sustainableRisk-Managed Swing Setup and Signal Analysis - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

What technical models suggest about Enanta Pharmaceuticals Inc.’s comebackProfitable Trading Blueprint with Entry Zones - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is it too late to sell Enanta Pharmaceuticals Inc.Weekly Trend Watch with Market Signals - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

How Interest Rate Changes Impact Enanta Pharmaceuticals Inc. Stock PerformanceSummary of Reliable Long-Term Trade Models - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Enanta Pharmaceuticals Inc. recovery potential after sell offSafe Entry Screening with Data Backed Analysis - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Enanta ENTA 2025Q3 Earnings Preview Downside Ahead on Weak Revenue Projections - AInvest

Aug 08, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Capitalizzazione:     |  Volume (24 ore):